| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.80e-06 | 5 | 132 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | calcium ion binding | PRSS1 PRSS2 COMP DSC3 CALML3 PCLO PCDHB5 PCDHB6 LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 LRP1 RASEF | 9.17e-06 | 749 | 132 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.48e-04 | 16 | 132 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.51e-04 | 85 | 132 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.44e-04 | 21 | 132 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 7.35e-04 | 27 | 132 | 3 | GO:0005044 | |
| HumanPheno | Limited elbow extension | 1.53e-05 | 60 | 47 | 6 | HP:0001377 | |
| HumanPheno | Abnormal periauricular region morphology | 2.09e-05 | 131 | 47 | 8 | HP:0000383 | |
| HumanPheno | Abnormal cheek morphology | 3.59e-05 | 282 | 47 | 11 | HP:0004426 | |
| HumanPheno | Abnormal metaphysis morphology | FLNB COMP RTEL1 ARX CHD7 PTH1R FBN1 LPIN2 RERE COG4 MED12 PCNT | 4.49e-05 | 344 | 47 | 12 | HP:0000944 |
| HumanPheno | Flared metaphysis | 4.80e-05 | 191 | 47 | 9 | HP:0003015 | |
| Domain | EGF | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 7.80e-08 | 235 | 128 | 12 | SM00181 |
| Domain | EGF_3 | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 7.80e-08 | 235 | 128 | 12 | PS50026 |
| Domain | EGF_CA | 1.32e-07 | 86 | 128 | 8 | PF07645 | |
| Domain | EGF-like_dom | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 1.46e-07 | 249 | 128 | 12 | IPR000742 |
| Domain | EGF_CA | 1.60e-07 | 122 | 128 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.84e-07 | 124 | 128 | 9 | IPR001881 | |
| Domain | EGF_1 | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 1.89e-07 | 255 | 128 | 12 | PS00022 |
| Domain | EGF-like_CS | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 2.43e-07 | 261 | 128 | 12 | IPR013032 |
| Domain | - | 2.50e-07 | 39 | 128 | 6 | 2.120.10.30 | |
| Domain | EGF_2 | COMP LRP1B TENM2 LRP8 THBD THBS2 THBS4 FBN1 NRXN3 MALRD1 TENM4 LRP1 | 2.86e-07 | 265 | 128 | 12 | PS01186 |
| Domain | 6-blade_b-propeller_TolB-like | 6.89e-07 | 46 | 128 | 6 | IPR011042 | |
| Domain | EGF | 2.49e-06 | 126 | 128 | 8 | PF00008 | |
| Domain | LY | 2.71e-06 | 15 | 128 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.71e-06 | 15 | 128 | 4 | IPR000033 | |
| Domain | TSP_3 | 3.11e-06 | 5 | 128 | 3 | PF02412 | |
| Domain | TSP3 | 3.11e-06 | 5 | 128 | 3 | PS51234 | |
| Domain | TSP_CTER | 3.11e-06 | 5 | 128 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 3.11e-06 | 5 | 128 | 3 | IPR017897 | |
| Domain | TSP_type-3_rpt | 3.11e-06 | 5 | 128 | 3 | IPR028974 | |
| Domain | - | 3.11e-06 | 5 | 128 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 3.11e-06 | 5 | 128 | 3 | IPR008859 | |
| Domain | TSP_C | 3.11e-06 | 5 | 128 | 3 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 3.11e-06 | 5 | 128 | 3 | IPR003367 | |
| Domain | EGF_Ca-bd_CS | 4.64e-06 | 97 | 128 | 7 | IPR018097 | |
| Domain | EGF_CA | 5.31e-06 | 99 | 128 | 7 | PS01187 | |
| Domain | cEGF | 2.80e-05 | 26 | 128 | 4 | PF12662 | |
| Domain | cEGF | 2.80e-05 | 26 | 128 | 4 | IPR026823 | |
| Domain | DUF5050 | 4.66e-05 | 2 | 128 | 2 | IPR032485 | |
| Domain | DUF5050 | 4.66e-05 | 2 | 128 | 2 | PF16472 | |
| Domain | ASX_HYDROXYL | 6.49e-05 | 100 | 128 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.98e-05 | 106 | 128 | 6 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 1.01e-04 | 156 | 128 | 7 | IPR009030 | |
| Domain | Ldl_recept_b | 1.08e-04 | 14 | 128 | 3 | PF00058 | |
| Domain | LDLRB | 1.08e-04 | 14 | 128 | 3 | PS51120 | |
| Domain | Rhs_assc_core | 1.39e-04 | 3 | 128 | 2 | IPR022385 | |
| Domain | COMP | 1.39e-04 | 3 | 128 | 2 | PF11598 | |
| Domain | Thbs/COMP_coiled-coil | 1.39e-04 | 3 | 128 | 2 | IPR024665 | |
| Domain | RGS | 1.44e-04 | 39 | 128 | 4 | IPR016137 | |
| Domain | LDLR_class-A_CS | 1.59e-04 | 40 | 128 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 2.52e-04 | 45 | 128 | 4 | PF00057 | |
| Domain | - | 2.75e-04 | 46 | 128 | 4 | 4.10.400.10 | |
| Domain | Tox-GHH_dom | 2.77e-04 | 4 | 128 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.77e-04 | 4 | 128 | 2 | PF15636 | |
| Domain | Ten_N | 2.77e-04 | 4 | 128 | 2 | IPR009471 | |
| Domain | Ten_N | 2.77e-04 | 4 | 128 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.77e-04 | 4 | 128 | 2 | PS51361 | |
| Domain | LDLRA_1 | 3.24e-04 | 48 | 128 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.51e-04 | 49 | 128 | 4 | IPR002172 | |
| Domain | LDLa | 3.51e-04 | 49 | 128 | 4 | SM00192 | |
| Domain | LDLRA_2 | 3.51e-04 | 49 | 128 | 4 | PS50068 | |
| Domain | TRYPSIN_SER | 3.86e-04 | 90 | 128 | 5 | IPR033116 | |
| Domain | - | 4.40e-04 | 22 | 128 | 3 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 4.40e-04 | 22 | 128 | 3 | IPR024066 | |
| Domain | YD | 4.60e-04 | 5 | 128 | 2 | IPR006530 | |
| Domain | - | 4.95e-04 | 95 | 128 | 5 | 2.60.120.200 | |
| Domain | TRYPSIN_HIS | 7.16e-04 | 103 | 128 | 5 | IPR018114 | |
| Domain | TRYPSIN_SER | 8.15e-04 | 106 | 128 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 8.50e-04 | 107 | 128 | 5 | PS00134 | |
| Domain | GoLoco | 9.57e-04 | 7 | 128 | 2 | SM00390 | |
| Domain | GoLoco | 9.57e-04 | 7 | 128 | 2 | PF02188 | |
| Domain | GoLoco_motif | 9.57e-04 | 7 | 128 | 2 | IPR003109 | |
| Domain | GOLOCO | 9.57e-04 | 7 | 128 | 2 | PS50877 | |
| Domain | Peptidase_S1A | 1.09e-03 | 113 | 128 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.18e-03 | 115 | 128 | 5 | PS50240 | |
| Domain | Tryp_SPc | 1.27e-03 | 117 | 128 | 5 | SM00020 | |
| Domain | IQ | 1.43e-03 | 71 | 128 | 4 | PF00612 | |
| Domain | Trypsin_dom | 1.47e-03 | 121 | 128 | 5 | IPR001254 | |
| Domain | Trypsin | 1.47e-03 | 121 | 128 | 5 | PF00089 | |
| Domain | Peptidase_S1_PA | 1.58e-03 | 123 | 128 | 5 | IPR009003 | |
| Domain | RGS | 1.75e-03 | 35 | 128 | 3 | PF00615 | |
| Domain | RGS | 1.75e-03 | 35 | 128 | 3 | SM00315 | |
| Domain | RGS | 1.90e-03 | 36 | 128 | 3 | PS50132 | |
| Domain | Myosin_head_motor_dom | 2.23e-03 | 38 | 128 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.23e-03 | 38 | 128 | 3 | PS51456 | |
| Domain | Myosin_head | 2.23e-03 | 38 | 128 | 3 | PF00063 | |
| Domain | MYSc | 2.23e-03 | 38 | 128 | 3 | SM00242 | |
| Domain | SH3_2 | 2.90e-03 | 86 | 128 | 4 | PF07653 | |
| Domain | SH3_2 | 2.90e-03 | 86 | 128 | 4 | IPR011511 | |
| Domain | IQ_motif_EF-hand-BS | 3.41e-03 | 90 | 128 | 4 | IPR000048 | |
| Domain | NHL | 3.46e-03 | 13 | 128 | 2 | PS51125 | |
| Domain | SH3 | 3.76e-03 | 216 | 128 | 6 | SM00326 | |
| Domain | SH3 | 3.76e-03 | 216 | 128 | 6 | PS50002 | |
| Domain | IQ | 3.84e-03 | 93 | 128 | 4 | PS50096 | |
| Domain | PDZ | 3.86e-03 | 151 | 128 | 5 | PS50106 | |
| Domain | PDZ | 3.97e-03 | 152 | 128 | 5 | IPR001478 | |
| Domain | PLAC | 4.02e-03 | 14 | 128 | 2 | PF08686 | |
| Domain | ConA-like_dom | 4.02e-03 | 219 | 128 | 6 | IPR013320 | |
| Domain | SH3_domain | 4.11e-03 | 220 | 128 | 6 | IPR001452 | |
| Domain | OAR | 4.62e-03 | 15 | 128 | 2 | PF03826 | |
| Domain | OAR | 5.25e-03 | 16 | 128 | 2 | PS50803 | |
| Domain | OAR_dom | 5.25e-03 | 16 | 128 | 2 | IPR003654 | |
| Domain | CarboxyPept-like_regulatory | 5.93e-03 | 17 | 128 | 2 | IPR008969 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 11073713 | ||
| Pubmed | The origin of trypsin: evidence for multiple gene duplications in trypsins. | 5.34e-08 | 3 | 132 | 3 | 9732462 | |
| Pubmed | FLNB MYH9 HK2 CNST PCLO IQSEC2 SUN1 SANBR GRIA1 MARCKSL1 LRP1B TENM2 SRPRB CEP170 NHSL1 TENM4 KCTD16 AKT2 CTNND2 | 6.61e-08 | 1139 | 132 | 19 | 36417873 | |
| Pubmed | FLNB MYH9 TTC28 CHD7 GREB1L KMT2D ZFHX4 ZNF608 LRP1 RERE MED12 PCNT | 7.40e-08 | 418 | 132 | 12 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 PDE3B ABL2 TTC28 KIF26B IQSEC2 NAA10 N4BP3 TRIP12 RGS12 C6orf132 CEP170 NHSL1 BOD1L1 RNF180 DOP1A | 1.88e-07 | 861 | 132 | 16 | 36931259 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.13e-07 | 4 | 132 | 3 | 19091768 | |
| Pubmed | AKAP6 FLNB TTC28 MYO6 CNST IQSEC2 NAP1L2 TRIP12 LRP1B POLR3B FBN1 OSBPL1A LRP1 MIGA1 ANKRD24 CTNND2 COG4 USP47 PCNT | 4.19e-07 | 1285 | 132 | 19 | 35914814 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 30622267 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 5.31e-07 | 5 | 132 | 3 | 17855024 | |
| Pubmed | 2.51e-06 | 225 | 132 | 8 | 12168954 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 2.95e-06 | 8 | 132 | 3 | 24460873 | |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 24122442 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ELOB FLNB MYH9 TTC28 MYO6 CALML3 BMS1 N4BP3 TRIP12 SRPRB USP19 POLR3B RTCA LRP1 USP47 | 6.83e-06 | 1005 | 132 | 15 | 19615732 |
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 19015242 | ||
| Pubmed | 1.15e-05 | 277 | 132 | 8 | 30745168 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB PDE3B MYO6 RTEL1 PPFIBP2 LRP8 CEP170 TLK1 ZNF608 SLC16A14 LRP1 RASEF BOD1L1 ANKRD24 RERE SCARA3 DOP1A PCNT | 1.41e-05 | 1489 | 132 | 18 | 28611215 |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.43e-05 | 2 | 132 | 2 | 15963947 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 1.43e-05 | 2 | 132 | 2 | 12871934 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11702203 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28475860 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 38876442 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 36191639 | ||
| Pubmed | Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. | 1.43e-05 | 2 | 132 | 2 | 27160021 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 1.43e-05 | 2 | 132 | 2 | 24484584 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31726086 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33202925 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 1.43e-05 | 2 | 132 | 2 | 30464261 | |
| Pubmed | Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. | 1.43e-05 | 2 | 132 | 2 | 17182969 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20484960 | ||
| Pubmed | Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice. | 1.43e-05 | 2 | 132 | 2 | 31557133 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25500815 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25546417 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17570828 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27846138 | ||
| Pubmed | Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2. | 1.43e-05 | 2 | 132 | 2 | 16246837 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 14695529 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15776435 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30877036 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23875975 | ||
| Pubmed | Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. | 1.43e-05 | 2 | 132 | 2 | 18461367 | |
| Pubmed | Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer. | 1.43e-05 | 2 | 132 | 2 | 15651064 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 2598466 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35089416 | ||
| Pubmed | Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. | 1.43e-05 | 2 | 132 | 2 | 18063422 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 1.89e-05 | 14 | 132 | 3 | 17662146 | |
| Pubmed | 1.92e-05 | 215 | 132 | 7 | 35973513 | ||
| Pubmed | 2.69e-05 | 407 | 132 | 9 | 12693553 | ||
| Pubmed | 3.50e-05 | 17 | 132 | 3 | 15944189 | ||
| Pubmed | 3.50e-05 | 17 | 132 | 3 | 20627871 | ||
| Pubmed | FLNB MYH9 BMS1 CHD7 TRIP12 DNTTIP2 CEP170 UTP20 MED12 USP47 PCNT | 4.18e-05 | 653 | 132 | 11 | 22586326 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 4.18e-05 | 18 | 132 | 3 | 35503090 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 24146905 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 15479433 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 15121769 | ||
| Pubmed | Trypsin-mediated enzymatic degradation of type II collagen in the human vitreous. | 4.28e-05 | 3 | 132 | 2 | 23882137 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28007623 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 30842629 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 4.28e-05 | 3 | 132 | 2 | 33910854 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 4.28e-05 | 3 | 132 | 2 | 26168731 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 25976449 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 26110235 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 18178577 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 4.28e-05 | 3 | 132 | 2 | 24251389 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 20472562 | ||
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 4.28e-05 | 3 | 132 | 2 | 12482844 | |
| Pubmed | Divergent roles of SPINK1 and PRSS2 variants in tropical calcific pancreatitis. | 4.28e-05 | 3 | 132 | 2 | 19077465 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 1763044 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 24105371 | ||
| Pubmed | Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools. | 4.28e-05 | 3 | 132 | 2 | 33498620 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 12807892 | ||
| Pubmed | 4.97e-05 | 104 | 132 | 5 | 9205841 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ELOB PDE3B HK2 TTC28 MYO6 PCLO SUN1 BMS1 PEX6 SRPRB USP19 NOM1 NFX1 MIGA1 RERE USP47 PCNT | 5.39e-05 | 1496 | 132 | 17 | 32877691 |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 6.76e-05 | 21 | 132 | 3 | 21337463 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 30190524 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 8.54e-05 | 4 | 132 | 2 | 10225957 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 12966030 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 25253127 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 8.54e-05 | 4 | 132 | 2 | 6338048 | |
| Pubmed | Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear. | 8.54e-05 | 4 | 132 | 2 | 15079858 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 33515547 | ||
| Pubmed | Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes. | 8.54e-05 | 4 | 132 | 2 | 22105175 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 20301293 | ||
| Pubmed | Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics. | 8.54e-05 | 4 | 132 | 2 | 28805986 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 3011602 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 8.54e-05 | 4 | 132 | 2 | 12000766 | |
| Pubmed | FLNB DLG5 MYH9 ABL2 DSC3 TTC28 MYO6 SRPRB CEP170 BOD1L1 MED12 | 8.59e-05 | 708 | 132 | 11 | 39231216 | |
| Pubmed | 9.10e-05 | 591 | 132 | 10 | 15231748 | ||
| Pubmed | 9.71e-05 | 481 | 132 | 9 | 28190767 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ELOB DLG5 ABL2 TTC28 LRP1B RGS12 RIMBP3 STXBP3 NFX1 RASEF USP47 PCNT | 1.04e-04 | 853 | 132 | 12 | 28718761 |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.05e-04 | 195 | 132 | 6 | 17110338 | |
| Pubmed | 1.05e-04 | 486 | 132 | 9 | 20936779 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB MYH9 PDE3B KIF26B PCLO IQSEC2 BMS1 TRIP12 THBS4 UTP20 BOD1L1 | 1.21e-04 | 736 | 132 | 11 | 29676528 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.27e-04 | 202 | 132 | 6 | 33005030 | |
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 22379635 | ||
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 18467703 | ||
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 16101684 | ||
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 24126057 | ||
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 17615572 | ||
| Pubmed | PPARγ contributes to PKM2 and HK2 expression in fatty liver. | 1.42e-04 | 5 | 132 | 2 | 22334075 | |
| Pubmed | 1.58e-04 | 71 | 132 | 4 | 33541421 | ||
| GeneFamily | Low density lipoprotein receptors | 2.49e-05 | 13 | 82 | 3 | 634 | |
| GeneFamily | Regulators of G-protein signaling | 1.13e-04 | 21 | 82 | 3 | 720 | |
| GeneFamily | Proteases, serine | 1.91e-04 | 63 | 82 | 4 | 738 | |
| GeneFamily | PDZ domain containing | 6.37e-04 | 152 | 82 | 5 | 1220 | |
| GeneFamily | DNA helicases | 2.64e-03 | 17 | 82 | 2 | 1167 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.30e-03 | 19 | 82 | 2 | 50 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 8.27e-07 | 200 | 132 | 9 | M304 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | SYNPO2 MYO6 PCDHB5 PCDHB6 TENM2 RGS3 PTH1R THBS2 FBN1 NRXN3 TENM4 ZFHX4 C11orf96 RNF180 SCARA3 | 7.77e-06 | 767 | 132 | 15 | M39209 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 3.00e-05 | 196 | 131 | 8 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_100 | 4.85e-05 | 12 | 131 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k1 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 5.52e-05 | 276 | 131 | 9 | gudmap_kidney_P1_CapMes_Crym_500 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 6.78e-05 | 69 | 131 | 5 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 7.80e-05 | 37 | 131 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200 | 8.09e-05 | 167 | 131 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 1.01e-04 | 120 | 131 | 6 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 1.08e-04 | 175 | 131 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | AKAP6 PAPPA2 SYNPO2 DSC3 KIF26B WNT6 SHOX2 LRP1B TENM2 CRHBP PTH1R HOXA11 THBD FBN1 CFAP52 ZFHX4 KCTD16 | 1.33e-04 | 994 | 131 | 17 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100 | 1.42e-04 | 43 | 131 | 4 | gudmap_kidney_P1_CapMes_Crym_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 1.83e-04 | 85 | 131 | 5 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 1.93e-04 | 86 | 131 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 2.05e-04 | 194 | 131 | 7 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.18e-04 | 196 | 131 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | PDE3B TTC28 MYO6 KIF26B PCLO CHD7 HOXA11 FBN1 MEX3A TENM4 ZNF608 LPIN2 RASEF SCARA3 | 2.21e-04 | 749 | 131 | 14 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | AKAP6 PAPPA2 SYNPO2 COMP KIF26B SHOX2 GRIA1 HOXA11 THBS2 FBN1 KCTD16 | 2.49e-04 | 494 | 131 | 11 | JC_fibro_500 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | PRSS1 KIF26B TMPRSS11E LRP1B TENM2 CRHBP PTH1R PRSS3P2 THBD TENM4 ZFHX4 | 2.54e-04 | 495 | 131 | 11 | PCBC_ratio_DE_vs_SC_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | SYNPO2 TTC28 KIF26B GRIA1 TENM2 CRHBP THBD NRXN3 TENM4 ZFHX4 | 2.62e-04 | 416 | 131 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 2.65e-04 | 92 | 131 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | NIBAN1 SYNPO2 DSC3 KIF26B BCAT1 RGS9 THBD THBS2 THBS4 FBN1 LRP1 | 2.81e-04 | 501 | 131 | 11 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | NIBAN1 SYNPO2 DSC3 KIF26B BCAT1 RGS9 THBD THBS2 THBS4 FBN1 LRP1 | 2.81e-04 | 501 | 131 | 11 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | NIBAN1 SYNPO2 DSC3 KIF26B BCAT1 RGS9 THBD THBS2 THBS4 FBN1 LRP1 | 2.81e-04 | 501 | 131 | 11 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | NIBAN1 SYNPO2 MYO6 KIF26B NAP1L2 BCAT1 CRHBP THBS2 THBS4 ZFHX4 | 2.83e-04 | 420 | 131 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 3.21e-04 | 53 | 131 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100_k1 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 3.21e-04 | 53 | 131 | 4 | gudmap_kidney_P1_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | SYNPO2 DSC3 KIF26B NAP1L2 SHOX2 TENM2 TLK1 STXBP3 ZFHX4 RNF180 | 3.35e-04 | 429 | 131 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 4.24e-04 | 57 | 131 | 4 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 4.34e-04 | 157 | 131 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#1 | 4.84e-04 | 59 | 131 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K1 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 4.88e-04 | 294 | 131 | 8 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AKAP6 SYNPO2 KIF26B NAP1L2 GRIA1 BCAT1 TENM2 LRP8 CEP170 NRXN3 ZFHX4 MIGA1 CTNND2 RNF180 | 5.36e-04 | 818 | 131 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PAPPA2 SYNPO2 MYH9 TTC28 KIF26B GRIA1 TENM2 CRHBP THBD NRXN3 TENM4 ZFHX4 MIGA1 ZNF646 | 5.36e-04 | 818 | 131 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 5.46e-04 | 164 | 131 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 5.83e-04 | 166 | 131 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 5.85e-04 | 62 | 131 | 4 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | AKAP6 NIBAN1 SYNPO2 DSC3 KIF26B NAP1L2 SHOX2 BCAT1 TENM2 LRP8 CEP170 NRXN3 ZFHX4 RNF180 | 5.97e-04 | 827 | 131 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | DLG5 NIBAN1 SYNPO2 TTC28 KIF26B PPFIBP2 THBS2 FBN1 ZFHX4 ADAMTS17 BOD1L1 ANKRD24 SCARA3 DOP1A | 6.48e-04 | 834 | 131 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 6.60e-04 | 64 | 131 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | SYNPO2 DSC3 KIF26B NAP1L2 SHOX2 MARCKSL1 TENM2 LRP8 CEP170 TLK1 STXBP3 ZFHX4 OSBPL1A RNF180 | 6.63e-04 | 836 | 131 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.24e-09 | 185 | 131 | 9 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 7.03e-09 | 196 | 131 | 9 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-08 | 184 | 131 | 8 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-07 | 197 | 131 | 8 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-07 | 197 | 131 | 8 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-07 | 197 | 131 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-07 | 198 | 131 | 8 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-07 | 200 | 131 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 1.03e-06 | 179 | 131 | 7 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-06 | 183 | 131 | 7 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-06 | 183 | 131 | 7 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 185 | 131 | 7 | a6874dd3030d04380cc3c01de1069461aad4ef45 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 188 | 131 | 7 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-06 | 192 | 131 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 192 | 131 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 1.71e-06 | 193 | 131 | 7 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 193 | 131 | 7 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 193 | 131 | 7 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-06 | 195 | 131 | 7 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-06 | 195 | 131 | 7 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-06 | 195 | 131 | 7 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-06 | 195 | 131 | 7 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.89e-06 | 196 | 131 | 7 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.89e-06 | 196 | 131 | 7 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-INs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 196 | 131 | 7 | 556e18eae05bf19259fe02848bcc9120aa2a9d29 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-06 | 197 | 131 | 7 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.96e-06 | 197 | 131 | 7 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 197 | 131 | 7 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.01e-06 | 126 | 131 | 6 | 83f3540683b3b175b10af059ab8898c46eaccc13 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.01e-06 | 126 | 131 | 6 | 6d5075d659dac7b96e6857f8485a7d2c4105d685 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.01e-06 | 126 | 131 | 6 | fd0001a0f3a0a4421f96fd21813c21cf6f01d40e | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.01e-06 | 126 | 131 | 6 | f20424f9baf3c4059cd6b701761e7595400fc47c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 198 | 131 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-06 | 198 | 131 | 7 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 198 | 131 | 7 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-06 | 199 | 131 | 7 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-06 | 200 | 131 | 7 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-06 | 200 | 131 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-06 | 200 | 131 | 7 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 200 | 131 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 200 | 131 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-06 | 200 | 131 | 7 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-06 | 200 | 131 | 7 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-06 | 166 | 131 | 6 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-06 | 166 | 131 | 6 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 170 | 131 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 171 | 131 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.29e-05 | 174 | 131 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-05 | 177 | 131 | 6 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 177 | 131 | 6 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 180 | 131 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 180 | 131 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 181 | 131 | 6 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-05 | 181 | 131 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 107 | 131 | 5 | 7dda60d30c12d9ee15cda5fcbc75c317ca2d026f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 107 | 131 | 5 | 5356499561a62a80ecd7d9a260aea87bc70543fd | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 107 | 131 | 5 | 8bdfb603ee0e8ca667847be016a9ee5f4f1712f8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 184 | 131 | 6 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-05 | 184 | 131 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 184 | 131 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 184 | 131 | 6 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 185 | 131 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-05 | 185 | 131 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 186 | 131 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-05 | 187 | 131 | 6 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 1.93e-05 | 187 | 131 | 6 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.99e-05 | 188 | 131 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 188 | 131 | 6 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 188 | 131 | 6 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 188 | 131 | 6 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 188 | 131 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.05e-05 | 189 | 131 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 189 | 131 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 2.05e-05 | 189 | 131 | 6 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.05e-05 | 189 | 131 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-05 | 190 | 131 | 6 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 190 | 131 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.18e-05 | 191 | 131 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 2.18e-05 | 191 | 131 | 6 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 191 | 131 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.18e-05 | 191 | 131 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-05 | 191 | 131 | 6 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.18e-05 | 191 | 131 | 6 | ff7204f9b645233548cf804cf6fe0c86417be87f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-05 | 191 | 131 | 6 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 191 | 131 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.18e-05 | 191 | 131 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-05 | 191 | 131 | 6 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| Computational | Metal / Ca ion binding. | 1.05e-04 | 133 | 88 | 7 | MODULE_324 | |
| Drug | I 333 | 1.76e-06 | 5 | 129 | 3 | CID000533915 | |
| Drug | O-4-(ethoxybutyl)berbamine | 6.12e-06 | 7 | 129 | 3 | CID000188375 | |
| Drug | AC1L1CUI | 6.15e-06 | 46 | 129 | 5 | CID000002069 | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.52e-05 | 194 | 129 | 8 | 6769_UP | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 5668_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 3000_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 7412_UP | |
| Drug | AP2PL | 2.75e-05 | 31 | 129 | 4 | CID000121867 | |
| Drug | conta-1(35),3,5,7(37),8,10,12,15,32(36),33-decaene-30-carboxylic acid | 5.58e-05 | 72 | 129 | 5 | CID000489933 | |
| Drug | N-allylglycine | 9.52e-05 | 3 | 129 | 2 | CID000076651 | |
| Drug | N-acetyl-L-norvaline methyl ester | 9.52e-05 | 3 | 129 | 2 | CID000150916 | |
| Drug | YAKR-CK | 9.52e-05 | 3 | 129 | 2 | CID005487256 | |
| Drug | 2 alpha-bromoacetoxyprogesterone | 9.52e-05 | 3 | 129 | 2 | CID000135256 | |
| Drug | methyl lignocerate | 9.52e-05 | 3 | 129 | 2 | CID000075546 | |
| Drug | GB-107 | 9.52e-05 | 3 | 129 | 2 | CID000056813 | |
| Drug | mitorubrinic acid | 9.52e-05 | 3 | 129 | 2 | CID000379537 | |
| Drug | ASA-PE | 9.52e-05 | 3 | 129 | 2 | CID003037809 | |
| Drug | schizopeptin 791 | 9.52e-05 | 3 | 129 | 2 | CID000636821 | |
| Drug | Lapg-nh2 | 9.52e-05 | 3 | 129 | 2 | CID003082486 | |
| Drug | Methotrexate-polylysine | 9.52e-05 | 3 | 129 | 2 | CID000163214 | |
| Drug | methyl octanesulfonate | 9.52e-05 | 3 | 129 | 2 | CID000165858 | |
| Drug | 3HFGB | 9.52e-05 | 3 | 129 | 2 | CID000126268 | |
| Drug | 4-chlorobenzenediazonium hexafluorophosphate | 9.52e-05 | 3 | 129 | 2 | CID002723983 | |
| Drug | 10-(carboxyethyl)flavin | 9.52e-05 | 3 | 129 | 2 | CID003082170 | |
| Drug | Z-Lys-CH2Cl | 9.52e-05 | 3 | 129 | 2 | CID000127335 | |
| Drug | 2,6-dimethyl-3-pyridinol | 9.52e-05 | 3 | 129 | 2 | CID000070732 | |
| Drug | N-phosphopyridoxyl-L-serine | 9.52e-05 | 3 | 129 | 2 | CID000195946 | |
| Drug | Z-Arg-OH | 9.52e-05 | 3 | 129 | 2 | CID000071055 | |
| Drug | p-amidinophenylpyruvate | 9.52e-05 | 3 | 129 | 2 | CID000444106 | |
| Drug | v 1194 | 9.52e-05 | 3 | 129 | 2 | CID000074702 | |
| Drug | L-TAPA | 9.52e-05 | 3 | 129 | 2 | CID000193734 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 190 | 129 | 7 | 7528_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 129 | 7 | 2831_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.18e-04 | 193 | 129 | 7 | 3378_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 3604_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 5265_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 5205_UP | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 4355_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 6557_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 4797_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 2431_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 6046_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 7497_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 4977_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 7325_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 5686_UP | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 3061_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; HL60; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 2567_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 7298_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 2216_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 3333_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.43e-04 | 199 | 129 | 7 | 1021_UP | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 2989_UP | |
| Drug | 0ZI | 1.89e-04 | 20 | 129 | 3 | CID000122235 | |
| Drug | 4-Amino-3-nitrobenzoic acid | 1.90e-04 | 4 | 129 | 2 | CID000074115 | |
| Drug | 4-ethylpiperidine | 1.90e-04 | 4 | 129 | 2 | CID000076704 | |
| Drug | torquatone | 1.90e-04 | 4 | 129 | 2 | CID000256516 | |
| Drug | mGBSOM | 1.90e-04 | 4 | 129 | 2 | CID003080804 | |
| Drug | Ba-O | 1.90e-04 | 4 | 129 | 2 | CID000002280 | |
| Drug | NSC-13568 | 1.90e-04 | 4 | 129 | 2 | CID000224783 | |
| Drug | xylaric acid | 1.90e-04 | 4 | 129 | 2 | CID003084064 | |
| Drug | AC1LAOUV | 1.90e-04 | 4 | 129 | 2 | CID000492408 | |
| Drug | 5'-S-propynyl-5'-thioadenosine | 1.90e-04 | 4 | 129 | 2 | CID000492409 | |
| Drug | AC1Q5JO7 | 1.90e-04 | 4 | 129 | 2 | CID000128324 | |
| Drug | Dsdgk | 1.90e-04 | 4 | 129 | 2 | CID000130454 | |
| Drug | NSC-45351 | 1.90e-04 | 4 | 129 | 2 | CID000018046 | |
| Drug | indomethacin-NHS | 1.90e-04 | 4 | 129 | 2 | CID000128571 | |
| Drug | bromomesaconic acid | 1.90e-04 | 4 | 129 | 2 | CID006449799 | |
| Drug | N-carbobenzoxyglycine vinyl ester | 1.90e-04 | 4 | 129 | 2 | CID000047309 | |
| Disease | Disproportionate short stature | 1.87e-05 | 77 | 124 | 5 | C0878659 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.68e-05 | 19 | 124 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Major Depressive Disorder | 7.83e-05 | 243 | 124 | 7 | C1269683 | |
| Disease | Weill-Marchesani syndrome | 1.05e-04 | 4 | 124 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.05e-04 | 4 | 124 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Unipolar Depression | 1.16e-04 | 259 | 124 | 7 | C0041696 | |
| Disease | Malignant neoplasm of breast | AKAP6 ADAMTS19 FLNB MYH9 DSC3 GSDMB KMT2D PER2 UTP20 AKT2 BOD1L1 MED12 DOP1A ZNF646 | 1.74e-04 | 1074 | 124 | 14 | C0006142 |
| Disease | PANCREATITIS, HEREDITARY | 1.74e-04 | 5 | 124 | 2 | 167800 | |
| Disease | Malignant Cystosarcoma Phyllodes | 1.74e-04 | 5 | 124 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 1.74e-04 | 5 | 124 | 2 | C0010701 | |
| Disease | Hereditary pancreatitis | 1.74e-04 | 5 | 124 | 2 | cv:C0238339 | |
| Disease | Autosomal Dominant Hereditary Pancreatitis | 1.74e-04 | 5 | 124 | 2 | C4080064 | |
| Disease | magnesium measurement | 1.75e-04 | 66 | 124 | 4 | EFO_0004845 | |
| Disease | brain measurement, hippocampal volume | 2.60e-04 | 6 | 124 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | age at menopause | 2.98e-04 | 302 | 124 | 7 | EFO_0004704 | |
| Disease | central nervous system cancer | 2.99e-04 | 31 | 124 | 3 | EFO_0000326 | |
| Disease | Mental Retardation, X-Linked 1 | 3.29e-04 | 32 | 124 | 3 | C2931498 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 3.60e-04 | 33 | 124 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Hereditary pancreatitis | 3.63e-04 | 7 | 124 | 2 | C0238339 | |
| Disease | triacylglycerol 58:6 measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0010440 | |
| Disease | descending aortic diameter | 5.27e-04 | 88 | 124 | 4 | EFO_0021788 | |
| Disease | Pancreatitis, Chronic | 6.19e-04 | 9 | 124 | 2 | C0149521 | |
| Disease | cerebrospinal fluid biomarker measurement, t-tau measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0004760, EFO_0006794 | |
| Disease | glioblastoma multiforme | 6.19e-04 | 9 | 124 | 2 | EFO_0000519 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 6.19e-04 | 9 | 124 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | asthma exacerbation measurement | 6.50e-04 | 93 | 124 | 4 | EFO_0007614 | |
| Disease | aortic aneurysm | 7.71e-04 | 10 | 124 | 2 | EFO_0001666 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 9.40e-04 | 11 | 124 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | triacylglycerol 58:12 measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0010439 | |
| Disease | Tourette syndrome | 1.23e-03 | 50 | 124 | 3 | EFO_0004895 | |
| Disease | Schizophrenia | GRIA1 RGS9 RGS12 CD163 LRP8 NRXN3 TENM4 LRP1 CTNND2 MED12 PCNT | 1.27e-03 | 883 | 124 | 11 | C0036341 |
| Disease | phosphatidylcholine 36:5 measurement | 1.54e-03 | 14 | 124 | 2 | EFO_0010383 | |
| Disease | sleep quality | 1.58e-03 | 118 | 124 | 4 | EFO_0005272 | |
| Disease | diet measurement | KIF26B GRIA1 BCAT1 LRP1B TENM2 RGS3 NRXN3 TENM4 ZNF608 NIM1K RERE CTNND2 | 1.58e-03 | 1049 | 124 | 12 | EFO_0008111 |
| Disease | creatine kinase measurement | 1.98e-03 | 59 | 124 | 3 | EFO_0004534 | |
| Disease | Schizoaffective disorder-bipolar type | 2.02e-03 | 16 | 124 | 2 | EFO_0009965 | |
| Disease | major depressive disorder (is_implicated_in) | 2.29e-03 | 17 | 124 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | irritable bowel syndrome | 2.31e-03 | 131 | 124 | 4 | EFO_0000555 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 2.56e-03 | 18 | 124 | 2 | C0342384 | |
| Disease | anorectal malformation | 2.86e-03 | 19 | 124 | 2 | MONDO_0019938 | |
| Disease | cataract | 3.01e-03 | 141 | 124 | 4 | MONDO_0005129 | |
| Disease | Nonorganic psychosis | 3.10e-03 | 69 | 124 | 3 | C0349204 | |
| Disease | opioid dependence | 3.33e-03 | 237 | 124 | 5 | EFO_0005611 | |
| Disease | neuritic plaque measurement | 3.64e-03 | 349 | 124 | 6 | EFO_0006798 | |
| Disease | lung cancer (is_implicated_in) | 3.78e-03 | 74 | 124 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Nonsyndromic genetic hearing loss | 4.07e-03 | 76 | 124 | 3 | cv:C5680182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITDFGLCKEGISDGA | 291 | P31751 | |
| EAGTSGCGIDAKQVE | 206 | Q5SW79 | |
| NGCSAECTGEGGSKE | 6 | P54687 | |
| ASCVEDGFEGDKTGG | 56 | P42684 | |
| ESDCTKLFSQGIGGE | 566 | Q9H9E3 | |
| KDSDGDGIGDACDNC | 396 | P49747 | |
| DGASSCLGKSLGSED | 236 | Q8TAX9 | |
| SCGEGDISEIESDMG | 1336 | Q5JWR5 | |
| EEGAACGESEVAGAT | 521 | Q8TF21 | |
| EEEDCTAGEKGISGS | 526 | Q14692 | |
| VGSSEEKAADKAEGG | 2931 | Q9P2D1 | |
| DGLLCGEANGKDAES | 791 | Q9UQB3 | |
| CDGIIGSAAKEDRCG | 676 | Q8TE56 | |
| GSAAKEDRCGVCSGD | 681 | Q8TE56 | |
| DAAAGLGDDGKCGEE | 36 | Q9ULW6 | |
| LGDDGKCGEEAAAGL | 41 | Q9ULW6 | |
| KCGEEAAAGLGEEGE | 46 | Q9ULW6 | |
| EVCLTGDSGAGEFKF | 751 | Q9Y5E4 | |
| EKTEEGSGPCAEAGS | 6 | Q8IVA1 | |
| EGDEDAAAALATSCG | 106 | Q8IZ41 | |
| EGKGDGCFKDISSIT | 221 | Q5T6V5 | |
| DGLKVCEVADATAGS | 1131 | A6NNM3 | |
| DGLKVCEVADATAGS | 1131 | A6NJZ7 | |
| SQKAGAEQGCSGDEE | 866 | P49796 | |
| CLMDSEDAGTGESGD | 646 | O75916 | |
| DCDATCGGGERKTTV | 926 | Q8TE59 | |
| ERKAEGGEEDSLGCL | 221 | P78412 | |
| GGEEDSLGCLTADTK | 226 | P78412 | |
| GLDTEGETCGNAEKL | 111 | P10746 | |
| GDGLDESDSICGAIT | 2746 | Q9NZR2 | |
| SGGLCDNKDDCGDGS | 2906 | Q9NZR2 | |
| ECGDNSDEDHCGGKL | 3741 | Q9NZR2 | |
| KGDKEGESGTSCNDL | 296 | Q68DU8 | |
| GGNCEIAGKSDADDF | 1441 | Q9UKN7 | |
| EAGAEEACTKAVGAD | 171 | Q5T442 | |
| EACTKAVGADGKAAG | 176 | Q5T442 | |
| DGSDEAAHCEGKTCG | 2761 | Q07954 | |
| GDKDCADGADESIAA | 2796 | Q07954 | |
| LGKCEAAGENSDGGD | 681 | Q5JU85 | |
| AEAGEAAAGKSERDC | 906 | Q2KJY2 | |
| CDVSFLQSEDGSGKG | 886 | P52789 | |
| TSDCKRVISGGGEGE | 426 | Q8N1V2 | |
| AENSADTGGDGESCL | 1301 | Q5SYE7 | |
| GSSSEACDFLKEDGN | 1331 | Q5SYE7 | |
| EAGEGDVSVGIKCDA | 771 | O75369 | |
| GKVGEAGLLSVDCSE | 1146 | O75369 | |
| GATETAAVGADCKPG | 1011 | O15055 | |
| KGGSLGCQTEADSDT | 3561 | Q9Y6V0 | |
| DFDLGSGIKLNGDCS | 226 | Q9HBH9 | |
| ESDGTDCCSGKSGEE | 591 | Q13370 | |
| AGGLTEEDEGELCAA | 656 | Q13608 | |
| GEACREEKGLAAEDS | 191 | P41227 | |
| CGVGEASLDKADSEG | 926 | Q8TDM6 | |
| LCGTDVGKSDGFGDF | 541 | Q12986 | |
| CGESEAADEKGSIAS | 541 | Q93074 | |
| CAGDKAGRDSCQGDS | 231 | Q9Y337 | |
| EDQSILCTGESGAGK | 166 | P35579 | |
| GGGGCRETAAAAEEK | 196 | P31270 | |
| ESGCQTESSKEGEEG | 26 | Q8IY84 | |
| EEKDCGGGDALSNGI | 516 | Q9BXW6 | |
| AGAGETLKQECDSLG | 1176 | Q9C091 | |
| VTKEDSALCGGGDIC | 56 | O95613 | |
| AGTKTGADLSDGTCE | 21 | Q8ND30 | |
| GAEDGSVDTCKGDSG | 236 | Q7RTY9 | |
| IGACSDEGTAQEGKA | 131 | P49006 | |
| AKGAEASAASEEEAG | 156 | P49006 | |
| GGGAAIDDIEFKNCT | 1661 | Q5VYJ5 | |
| GDGKVSERLGEECDD | 1116 | Q9BXP8 | |
| GDGCSKVCELEEGFN | 1136 | Q9BXP8 | |
| DDAVTSAGSEEKCDG | 1651 | Q8NFC6 | |
| EGGRICENGADDDKL | 596 | Q5T0Z8 | |
| EGETLAFLCKAGGAE | 426 | Q93033 | |
| AGSVGCCSEKQEEDG | 861 | Q14574 | |
| KKSSAGCEGIGDFVE | 231 | P24387 | |
| LDDGKTLGECGFTSQ | 51 | Q15370 | |
| GDGIKCTDLDECSNG | 1356 | P35555 | |
| DAEGKDGEDSVCLSA | 301 | Q96QS3 | |
| DKDGDGCITTRELGT | 21 | P27482 | |
| SEAGEKADGVASKGD | 4126 | Q8NDH2 | |
| ECGSGGGDSKDKTSA | 786 | P42261 | |
| AEDAGVICSKGADLS | 251 | Q86VB7 | |
| AGGDGDALCVTEEDL | 6 | Q6AZY7 | |
| DVSTFSEGGDCKEPD | 51 | Q8NCQ7 | |
| FIDAEELCSGGVKAG | 41 | Q8NG08 | |
| IDDSLDQDEVGGGSC | 651 | Q6PJW8 | |
| EKDCEGGADEAGCAT | 151 | Q14114 | |
| GCDKEALLTGGGSEN | 146 | Q86T96 | |
| DVEATDGGGLSGKCS | 316 | Q9Y5E3 | |
| CLSSAEDSGVDEGQG | 561 | Q8IWE5 | |
| EDEACGSIKLGAGDA | 236 | Q8NAN2 | |
| AVCRGKASEGLDFSD | 621 | Q9NZ71 | |
| GDTAVGGDACSLSKL | 576 | Q4VX76 | |
| GVACADEKAESDGEE | 2591 | O75691 | |
| CSAKGGRGDVGSADI | 246 | Q9Y5M8 | |
| VGFLEGGKDSCQGDS | 186 | Q8NHM4 | |
| IGTDCDSGKVDGGDS | 476 | P07204 | |
| GDSSGEGVCDKSPLE | 191 | P08582 | |
| TEEKDGGLGNEETLC | 246 | Q7RTX9 | |
| DGLKVCEVADATAGS | 1131 | Q9UFD9 | |
| LSDQGSDGCDDDGLV | 386 | Q9HDB5 | |
| GAKEPTGCTEAGRDD | 36 | O60902 | |
| KDNECEEESGGIRGL | 846 | Q13621 | |
| EARCGDGGKAIDATL | 1341 | Q9NT68 | |
| SEDGDITDKSLCGSG | 321 | Q5C9Z4 | |
| GGSTEDGCVAASRDD | 346 | Q9P2R6 | |
| DTVSDVGVGLCDEKG | 501 | Q6NSI8 | |
| CKTEQDLALGTDAEG | 366 | O00186 | |
| EPACAEGSVKDSGVD | 216 | Q7Z7C7 | |
| VDDKGGCEEDNASAV | 301 | Q13023 | |
| RDCGSDAAEDSASKG | 76 | Q7Z7L8 | |
| SDLTKFGDCGGSDDE | 386 | Q5QJE6 | |
| SLEGKTDACQGDSGG | 361 | Q9UL52 | |
| RDKDGDGVGDACDSC | 591 | P35443 | |
| DGTACGEIKITDFGL | 596 | Q9UKI8 | |
| LGSGLGAEIDSAECV | 86 | Q9H4F1 | |
| KSGEGENTDKLECGT | 1891 | Q86UP3 | |
| ASKELECAEDPGSAG | 1036 | O94966 | |
| EGTDLEGDMLDCSGS | 46 | Q6ZSR9 | |
| DGASGGSDQLCERDA | 16 | Q13156 | |
| SDGELTGADLKDCVS | 671 | O14924 | |
| KASGSGLCEGDEVVS | 41 | Q9UMS6 | |
| EGDKEDTCEVAFLGA | 426 | Q9UMS6 | |
| EGRGGKCTEEGDASQ | 826 | Q9BZQ8 | |
| GADKKAEAGAGSATE | 146 | Q9NQ39 | |
| DGFLNGSCSGLDEEA | 561 | Q03431 | |
| CFGGSAKDRGLLEDE | 21 | A1L020 | |
| DLCDGQLEGAEIGST | 61 | O00442 | |
| GGDSGNVDDDCERVK | 846 | Q96K76 | |
| DGDCLQAESEGDKCG | 726 | O15015 | |
| GNEKEDGEAADTVGC | 326 | Q969P6 | |
| GCGDDVDFGDEKSRL | 171 | Q9Y6F9 | |
| TACGDSKDNDGDGLV | 836 | Q6N022 | |
| FDDTRCGDGGKATEA | 1331 | Q6N022 | |
| VLATECGQGEEKSEG | 2276 | P08922 | |
| GTAFGGSKVKDVCED | 961 | Q9NW08 | |
| VGFLEGGKDSCQGDS | 186 | P07478 | |
| KDRALESDAACGLGG | 991 | Q96AY4 | |
| AATAGAGSCGKSKEE | 176 | Q9ULD9 | |
| ENEACAVLGGSDSEK | 31 | Q8N806 | |
| PGAAETGDVCEDTFK | 306 | Q9P0L1 | |
| TACTLGDGEAVGADS | 61 | O94901 | |
| VGFLEGGKDSCQGDS | 186 | P07477 | |
| SGQEDFDKDGIGDAC | 726 | P35442 | |
| CVKSGSGSESTGAEE | 156 | Q14669 | |
| LLCDAGTAISGGKAE | 1271 | O14686 | |
| CDVGVSSDDDKGAQA | 181 | Q92539 | |
| DFEEAGSTSGGCNLK | 351 | Q9UM54 | |
| CEELKRGLGDEDGSN | 266 | O15049 |